Tumor SPARC Microenvironment Signature and Plasma Levels in a Phase II Trial of Unresectable Stage IV Melanoma Treated With nab-Paclitaxel and Carboplatin: A Translational Study of NCCTG Trial N057E
   Google Scholar   
Citation:
J Clin Oncol vol 28 (15s) abstr 8578
Meeting Instance:
ASCO 2010
Year:
2010
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
265  
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
Experimental    
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                     
Networks:
 
Study
NCCTG-N057E
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: